What is the strongest evidence after menopause?
Trials combining creatine with resistance training provide the strongest basis here for discussing muscle-related outcomes. The 2026 review found modest average benefits in some measures. Participants, training and doses differed between trials, so that finding is more specific than a claim that creatine generally improves health after menopause. [1]
Has creatine been shown to ease menopause symptoms?
A small trial in peri- and postmenopausal women found selected cognitive signals using alternative creatine forms. Its primary mental-fatigue outcome did not show a significant treatment-by-time effect. Positive secondary results cannot establish general symptom relief. Research has not established a reliable treatment for perimenopausal brain fog or wider menopause symptoms. [4] [3]
What about bone health after menopause?
In a two-year trial of 237 postmenopausal women, creatine alongside exercise did not improve the main bone-density outcomes. Selected secondary measures showed differences, which are worth studying further. They are not evidence that creatine reduces fractures or a reason to replace an individual bone-health plan. [2]
Look a little closer
What are the limits of this evidence?
Each card separates the finding from the limits. The participants, formulation and duration are part of the answer.
Postmenopausal meta-analysis, 2026
Small lean-mass and leg-press strength benefits were found overall; bone density was unchanged.
- Who
- 608 women randomised in seven trials; lean mass pooled 338 women, leg-press strength 111
- Dose
- Varied; benefits were seen in trials using at least 5 g/day with resistance training
- Duration
- 12 to 104 weeks
- Limits
- Mostly some risk-of-bias concerns; not prospectively registered. Dose and training varied together. Lean mass includes water, and its prediction interval included no effect.
Chilibeck et al., 2023
No added bone-density or measured strength benefit; selected bone-geometry measures and walking time favoured creatine.
- Who
- 237 postmenopausal women, mean age 59, randomised
- Dose
- 0.14 g/kg/day
- Duration
- 2 years
- Limits
- Both groups exercised. Lean-mass benefit appeared in a valid-completers subanalysis. Secondary bone geometry findings are not proof of fewer fractures.
Which sources did we check?
- Creatine monohydrate for lean mass, strength, and bone density in postmenopausal women: a systematic review and meta-analysis ↗Journal of the International Society of Sports Nutrition · 2026 · Study details and limits
- A 2-yr Randomized Controlled Trial on Creatine Supplementation during Exercise for Postmenopausal Bone Health ↗Medicine & Science in Sports & Exercise · 2023 · Study details and limits
- The Effects of 8-Week Creatine Hydrochloride and Creatine Ethyl Ester Supplementation on Cognition, Clinical Outcomes, and Brain Creatine Levels in Perimenopausal and Menopausal Women (CONCRET-MENOPA): A Randomized Controlled Trial ↗Journal of the American Nutrition Association · 2025 · Study details and limits
- Creatine in women’s health: bridging the gap from menstruation through pregnancy to menopause ↗Journal of the International Society of Sports Nutrition · 2025 · Study details and limits